2007

Pharmacotherapy of Diabetes: New Developments

Improving Life and Prognosis for Diabetic Patients

Editors:

ISBN: 978-0-387-69736-9 (Print) 978-0-387-69737-6 (Online)

Table of contents (28 chapters)

previous Page of 2
  1. Front Matter

    Pages i-xv

  2. Overview

    1. No Access

      Book Chapter

      Pages 3-8

      Pharmacoepidemiology of Diabetes

    2. No Access

      Book Chapter

      Pages 9-16

      New Definitions of Diabetes: Consequences

  3. Pharmacotherapy of Diabetes

    1. No Access

      Book Chapter

      Pages 19-30

      The Insulin Resistance Syndrome: Concept and Therapeutic Approaches

    2. No Access

      Book Chapter

      Pages 31-37

      Medical Emergencies – Diabetic Ketoacidosis and Hyperosmolar Hyperglycaemia

    3. No Access

      Book Chapter

      Pages 39-39

      Notes on the Use of Glucagon in Type 1 Diabetes

    4. No Access

      Book Chapter

      Pages 41-51

      Insulin and New Insulin Analogues, Insulin Pumps and Inhaled Insulin in Type 1 Diabetes

    5. No Access

      Book Chapter

      Pages 53-65

      Insulin and New Insulin Analogues with Focus on Type 2 Diabetes

    6. No Access

      Book Chapter

      Pages 67-76

      The Place of Insulin Secretagogues in the Treatment of Type 2 Diabetes in the Twenty-First Century

    7. No Access

      Book Chapter

      Pages 77-86

      Metformin – from Devil to Angel

    8. No Access

      Book Chapter

      Pages 87-97

      The Glitazones, Lessons so Far

    9. No Access

      Book Chapter

      Pages 99-109

      Antidiabetic Combination Therapy

    10. No Access

      Book Chapter

      Pages 111-141

      The Incretin Modulators – Incretin Mimetics (GLP-1 Receptor Agonists) and Incretin Enhancers (DPP-4 Inhibitors)

    11. No Access

      Book Chapter

      Pages 143-152

      The Role of Alpha-Glucosidase Inhibitors (Acarbose)

    12. No Access

      Book Chapter

      Pages 153-163

      Multifactorial Intervention in Type 2 Diabetes

  4. Treating the Comorbid Patient

    1. No Access

      Book Chapter

      Pages 167-171

      Obesity and Pharmacological Treatment

    2. No Access

      Book Chapter

      Pages 173-186

      Management of Diabetic Dyslipidaemia

    3. No Access

      Book Chapter

      Pages 187-197

      Coronary Intervention and Ischemic Cardioprotection in Diabetic Patients

  5. Diabetic Complications and Side-effects

    1. No Access

      Book Chapter

      Pages 201-210

      ACE-I and ARB and Blood Pressure Lowering, Including Effect on Renal Disease. Treatment of Advanced Diabetic Renal Disease

    2. No Access

      Book Chapter

      Pages 211-218

      Aspirin and Antiplatelet Drugs in the Prevention of Cardiovascular Complications of Diabetes

    3. No Access

      Book Chapter

      Pages 219-228

      Glycosylation Inhibitors, PKC Inhibitors and Related Interventions Against Complications

previous Page of 2